La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Regis Healthcare Crescita futura

Future criteri di controllo 5/6

Regis Healthcare prevede che gli utili e i ricavi cresceranno rispettivamente di 96.2% e 8.6% all'anno. Si prevede che l'EPS crescerà di 94.1% all'anno. Si prevede che il ritorno sul capitale proprio sarà di 184% in 3 anni.

Informazioni chiave

48.8%

Tasso di crescita degli utili

49.8%

Tasso di crescita dell'EPS

Healthcare crescita degli utili	25.2%
Tasso di crescita dei ricavi	7.2%
Rendimento futuro del capitale proprio	133.0%
Copertura analitica	Good
Ultimo aggiornamento	26 Sep 2024

Aggiornamenti recenti sulla crescita futura

Recent updates

Regis Healthcare Limited's (ASX:REG) P/S Is Still On The Mark Following 31% Share Price Bounce

Sep 12

Is There An Opportunity With Regis Healthcare Limited's (ASX:REG) 38% Undervaluation?

May 02

At AU$3.94, Is It Time To Put Regis Healthcare Limited (ASX:REG) On Your Watch List?

Mar 21

Regis Healthcare (ASX:REG) Has Announced A Dividend Of A$0.0628

Feb 28

Regis Healthcare Limited's (ASX:REG) CEO Compensation Looks Acceptable To Us And Here's Why

Oct 18

Regis Healthcare's (ASX:REG) Shareholders Will Receive A Smaller Dividend Than Last Year

Aug 26

Regis Healthcare Limited's (ASX:REG) Intrinsic Value Is Potentially 34% Above Its Share Price

Feb 25

Is Regis Healthcare Limited (ASX:REG) Potentially Undervalued?

May 27

Estimating The Fair Value Of Regis Healthcare Limited (ASX:REG)

May 09

Should You Be Excited About Regis Healthcare Limited's (ASX:REG) 23% Return On Equity?

Aug 10

At AU$1.32, Is Regis Healthcare Limited (ASX:REG) Worth Looking At Closely?

Aug 10

Reflecting on Regis Healthcare's (ASX:REG) Share Price Returns Over The Last Five Years

Jul 14

Is Regis Healthcare Limited (ASX:REG) An Attractive Dividend Stock?

Jul 02

Previsioni di crescita degli utili e dei ricavi

ASX:REG - Stime future degli analisti e dati finanziari passati (AUD Millions )
Data	Ricavi	Guadagni	Flusso di cassa libero	Liquidità dell'operazione	Avg. Numero di analisti
6/30/2027	1,283	87	170	221	6
6/30/2026	1,206	66	127	202	6
6/30/2025	1,133	48	2	197	6
6/30/2024	1,014	-21	187	252	N/A
3/31/2024	947	-18	159	224	N/A
12/31/2023	880	-15	132	195	N/A
9/30/2023	830	-22	93	150	N/A
6/30/2023	781	-28	54	105	N/A
3/31/2023	761	-45	34	78	N/A
12/31/2022	741	-61	14	50	N/A
9/30/2022	733	-50	41	82	N/A
6/30/2022	725	-39	68	115	N/A
3/31/2022	719	-16	N/A	N/A	N/A
12/31/2021	713	8	104	143	N/A
9/30/2021	707	14	96	124	N/A
6/30/2021	701	20	88	105	N/A
3/31/2021	700	8	N/A	N/A	N/A
12/31/2020	699	-4	86	105	N/A
9/30/2020	688	-2	87	116	N/A
6/30/2020	678	-1	88	127	N/A
3/31/2020	655	21	111	156	N/A
12/31/2019	661	39	134	186	N/A
9/30/2019	654	45	144	203	N/A
6/30/2019	647	51	155	220	N/A
3/31/2019	632	51	101	204	N/A
12/31/2018	617	50	47	188	N/A
9/30/2018	606	52	-13	161	N/A
6/30/2018	594	54	-74	134	N/A
3/31/2018	586	56	N/A	129	N/A
12/31/2017	577	57	N/A	124	N/A
9/30/2017	571	59	N/A	138	N/A
6/30/2017	565	61	N/A	151	N/A
3/31/2017	547	55	N/A	151	N/A
12/31/2016	529	50	N/A	152	N/A
9/30/2016	505	48	N/A	143	N/A
6/30/2016	481	47	N/A	134	N/A
3/31/2016	468	59	N/A	146	N/A
12/31/2015	455	71	N/A	159	N/A
9/30/2015	446	64	N/A	143	N/A
6/30/2015	438	58	N/A	127	N/A
3/31/2015	433	28	N/A	119	N/A
12/31/2014	428	-1	N/A	110	N/A
9/30/2014	419	0	N/A	122	N/A
6/30/2014	410	1	N/A	135	N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: Si prevede che REG diventerà redditizio nei prossimi 3 anni, il che è considerato una crescita più rapida del tasso di risparmio ( 2.4% ).

Guadagni vs Mercato: Si prevede che REG diventerà redditizia nei prossimi 3 anni, il che è considerato una crescita superiore alla media del mercato.

Guadagni ad alta crescita: Si prevede REG diventerà redditizia nei prossimi 3 anni.

Ricavi vs Mercato: Si prevede che il fatturato di REG ( 8.4% all'anno) crescerà più rapidamente del mercato Australian ( 5.4% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di REG ( 8.6% all'anno) crescerà più lentamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Si prevede che il Return on Equity di REG sarà molto alto tra 3 anni ( 184 %).

Regis Healthcare Crescita futura

Future criteri di controllo 5/6

Informazioni chiave

Aggiornamenti recenti sulla crescita futura

Price target increased by 7.5% to AU$4.74

Price target increased by 8.5% to AU$4.37

Price target increased by 7.3% to AU$3.77

Price target increased by 9.0% to AU$3.52

Price target increased by 7.4% to AU$3.43

Price target increased by 11% to AU$3.07

Recent updates

Regis Healthcare Limited, Annual General Meeting, Nov 26, 2024

Regis Healthcare Limited (ASX:REG) agreed to acquire Two residential aged care homes in Capel Sound and Mornington from Ti Tree Operations Pty Ltd for AUD 35.5 million.

Regis Healthcare Limited's (ASX:REG) P/S Is Still On The Mark Following 31% Share Price Bounce

Final dividend of AU$0.066 announced

Price target increased by 7.5% to AU$4.74

Full year 2024 earnings: Revenues exceed analyst expectations

Regis Healthcare Limited to Report Second Half, 2024 Results on Aug 26, 2024

Price target increased by 8.5% to AU$4.37

Non-Executive Director recently sold AU$68m worth of stock

Is There An Opportunity With Regis Healthcare Limited's (ASX:REG) 38% Undervaluation?

At AU$3.94, Is It Time To Put Regis Healthcare Limited (ASX:REG) On Your Watch List?

Upcoming dividend of AU$0.063 per share

Regis Healthcare (ASX:REG) Has Announced A Dividend Of A$0.0628

First half dividend increased to AU$0.063

Price target increased by 7.3% to AU$3.77

Price target increased by 9.0% to AU$3.52

Price target increased by 7.4% to AU$3.43

Regis Healthcare Limited to Report First Half, 2024 Results on Feb 26, 2024

Regis Healthcare Limited Announces Appointment of Jodie Leonard as Independent Non-Executive Director and to Chair the People and Remuneration Committee

Regis Healthcare Limited Announces Appointment of Jodie Leonard as Independent Non-Executive Director and to Chair the People and Remuneration Committee

Regis Healthcare Limited (ASX:REG) agreed to acquire Cpsm Pty Ltd for AUD 74.2 million.

Price target increased by 11% to AU$3.07

Price target increased by 7.0% to AU$2.77

Consensus EPS estimates upgraded to AU$0.083 loss

Price target increased by 8.7% to AU$2.74

Regis Healthcare Limited's (ASX:REG) CEO Compensation Looks Acceptable To Us And Here's Why

Price target increased by 8.8% to AU$2.59

Upcoming dividend of AU$0.075 per share at 3.8% yield

Regis Healthcare (ASX:REG) Is Paying Out A Larger Dividend Than Last Year

Consensus EPS estimates fall by 14%, revenue upgraded

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Regis Healthcare Limited Announces Dividend for the Six Months Ended June 30, 2023, Payable on September 27, 2023

Regis Healthcare Limited Announces the Resignation of Rebecca Dean as Company Secretary

Regis Healthcare Limited, Annual General Meeting, Oct 24, 2023

Regis Healthcare Limited to Report Fiscal Year 2023 Results on Aug 25, 2023

Price target increased by 7.6% to AU$2.33

Consensus EPS estimates fall by 18%

Upcoming dividend of AU$0.02 per share at 3.7% yield

Regis Healthcare (ASX:REG) Is Paying Out Less In Dividends Than Last Year

First half 2023 earnings released: AU$0.086 loss per share (vs AU$0.012 loss in 1H 2022)

Regis Healthcare Limited to Report First Half, 2023 Results on Feb 24, 2023

Consensus forecasts updated

Is Regis Healthcare (ASX:REG) Using Debt Sensibly?

Upcoming dividend of AU$0.023 per share

Regis Healthcare's (ASX:REG) Shareholders Will Receive A Smaller Dividend Than Last Year

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Regis Healthcare Limited Announces Fiscal Year 2022 Final Dividend, Payable on September 30, 2022

Regis Healthcare Limited, Annual General Meeting, Oct 25, 2022

Consensus forecasts updated

Consensus forecasts updated

Regis Healthcare Limited to Report Fiscal Year 2022 Results on Aug 24, 2022

Now 21% undervalued

Consensus forecasts updated

Upcoming dividend of AU$0.035 per share

Regis Healthcare Limited's (ASX:REG) Intrinsic Value Is Potentially 34% Above Its Share Price

First half 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Regis Healthcare Limited Declares Franked Ordinary Dividend for the Six Months Ended December 31, 2021, Payable on April 8, 2022

Upcoming dividend of AU$0.046 per share

Full year 2021 earnings released

Price target increased to AU$2.49

Consensus forecasts updated

Insufficient new directors

Is Regis Healthcare Limited (ASX:REG) Potentially Undervalued?

Price target increased to AU$2.22

Estimating The Fair Value Of Regis Healthcare Limited (ASX:REG)

Regis Healthcare Limited to Report Fiscal Year 2021 Results on Aug 31, 2021

Regis Healthcare Limited, Annual General Meeting, Oct 26, 2021

Regis Healthcare Limited to Report First Half, 2021 Results on Feb 24, 2021

Washington H. Soul Pattinson and Company Limited and Ashburn Pty Limited cancelled the acquisition of the remaining 72.76% stake in Regis Healthcare Limited (ASX:REG) from Bryan Dorman and others.